Vasodilating mechanisms of levosimendan.
Yokoshiki
Hisashi
H
Sperelakis
Nicholas
N
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D002118:Calcium / Q000378:metabolism; D006801:Humans; D006835:Hydrazones / Q000494:pharmacology*; D015640:Ion Channel Gating; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism; D015221:Potassium Channels / Q000187:drug effects / Q000502:physiology; D011724:Pyridazines / Q000494:pharmacology*; D000077464:Simendan; D014665:Vasodilator Agents / Q000494:pharmacology*
D006835:Hydrazones; D015221:Potassium Channels; D011724:Pyridazines; D014665:Vasodilator Agents; D000077464:Simendan; D000255:Adenosine Triphosphate; D002118:Calcium